The Journal of Clinical Immunology is an international journal that publishes high impact papers in the area of human immunology that explore the diagnosis, pathogenesis, prognosis, or treatment of human diseases. The Journal is particularly focused on primary immunodeficiencies and related diseases. These include inborn errors of immunity, in the broad sense of the term, their underlying genotypes, and their diverse phenotypes, including infection, malignancy, allergy, auto-inflammation, and autoimmunity. We consider a wide range of studies in this area, ranging from genetic discovery, clinical description, immunologic assessment, diagnostic approach, prognosis evaluation, and treatment intervention. This well-established journal publishes articles on basic, translational, and clinical studies including relevant animal models and case reports of general significance.
- Publishes high impact papers with a focus on primary immunodeficiencies and related diseases
- Offers articles on basic, translational and clinical studies of immunology
- Keeps researchers and academics current on developments in immunology
Journal information
- Editors-in-Chief
-
- Vincent Bonagura,
- Jean-Laurent Casanova
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 6.780 (2019)
- Impact factor
- 4.857 (2019)
- Five year impact factor
- 31 days
- Submission to first decision
- 131 days
- Submission to acceptance
- 256,681 (2019)
- Downloads
Latest issue
Latest articles
-
-
Successful Treatment of Skewed Lyonization Associated with X-Linked CGD in a Female Presenting with Recalcitrant Crohn’s Disease
Authors (first, second and last of 8)
-
-
Disseminated Infectious Disease Caused by Histoplasma capsulatum in an Adult Patient as First Manifestation of Inherited IL-12Rβ1 Deficiency
Authors (first, second and last of 9)
-
An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency
Authors (first, second and last of 16)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time. Please see this letter from the Editors-in-Chief for more information.
-
CME Credit
In collaboration with the Clinical Immunology Society, the Journal offers the opportunity to obtain CME credit.
-
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1573-2592
- Print ISSN
- 0271-9142
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Psyndex
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
